×
Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.
Dopamine d2 Receptor Antikörper (AA 214-373)
DRD2
Reaktivität: Human
WB
Wirt: Kaninchen
Polyclonal
unconjugated
Produktnummer ABIN6139821
Produktdetails anti-Dopamine d2 Receptor Antikörper
(ausblenden)
Target
Alle Dopamine d2 Receptor (DRD2) Antikörper anzeigen
Dopamine d2 Receptor (DRD2)
(Dopamine Receptor D2 (DRD2))
Bindungsspezifität
Alle Epitope für Dopamine d2 Receptor Antikörper
AA 214-373
Reaktivität
Alle Reaktivitäten für Dopamine d2 Receptor Antikörper
Human
Wirt
Alle Wirte für Dopamine d2 Receptor Antikörper
Kaninchen
Klonalität
Alle Klonalitäten für Dopamine d2 Receptor Antikörper
Polyklonal
Konjugat
Alle Konjugate für Dopamine d2 Receptor Antikörper
Dieser Dopamine d2 Receptor Antikörper ist unkonjugiert
Applikation
Alle Applikationen für Dopamine d2 Receptor Antikörper
Western Blotting (WB)
Sequenz
IVLRRRRKRV NTKRSSRAFR AHLRAPLKGN CTHPEDMKLC TVIMKSNGSF PVNRRRVEAA RRAQELEMEM LSSTSPPERT RYSPIPPSHH QLTLPDPSHH GLHSTPDSPA KPEKNGHAKD HPKIAKIFEI QTMPNGKTRT SLKTMSRRKL SQQKEKKATQ
Kreuzreaktivität
Human, Maus, Ratte
Produktmerkmale
Polyclonal Antibodies
Aufreinigung
Affinity purification
Immunogen
Recombinant fusion protein containing a sequence corresponding to amino acids 214-373 of human DRD2 (NP_000786.1).
Isotyp
IgG
Top Product
Discover our top product DRD2 Primärantikörper
Alternativen
(anzeigen)
Anwendungsinformationen
(ausblenden)
Applikationshinweise
WB,1:500 - 1:1000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Handhabung
(ausblenden)
Format
Liquid
Buffer
PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20°C. Avoid freeze / thaw cycles.
Details zu Dopamine d2 Receptor
(ausblenden)
Target
Dopamine d2 Receptor (DRD2)
(Dopamine Receptor D2 (DRD2))
Andere Bezeichnung
DRD2 (DRD2 Produkte )
Synonyme
D2DR antikoerper, D2R antikoerper, drd2b antikoerper, d2r2 antikoerper, Drd-2 antikoerper, d2dr antikoerper, d2r antikoerper, drd2 antikoerper, drd2-B antikoerper, DRD2 antikoerper, D2 antikoerper, CG18741 antikoerper, CG7569 antikoerper, DAMB antikoerper, DDR2 antikoerper, DOPR2 antikoerper, DOPR99B antikoerper, Dar2 antikoerper, Dmel\\CG18741 antikoerper, DopD1 antikoerper, DopR99B antikoerper, DopRII antikoerper, dopamine receptor D2 antikoerper, dopamine receptor D2 like antikoerper, dopamine receptor D2 L homeolog antikoerper, dopamine receptor D2 S homeolog antikoerper, Dopamine 1-like receptor 2 antikoerper, DRD2 antikoerper, drd2l antikoerper, drd2 antikoerper, Drd2 antikoerper, drd2.L antikoerper, drd2.S antikoerper, Dop1R2 antikoerper
Hintergrund
This gene encodes the D2 subtype of the dopamine receptor. This G-protein coupled receptor inhibits adenylyl cyclase activity. A missense mutation in this gene causes myoclonus dystonia, other mutations have been associated with schizophrenia. Alternative splicing of this gene results in two transcript variants encoding different isoforms. A third variant has been described, but it has not been determined whether this form is normal or due to aberrant splicing.,DRD2,D2DR,D2R,Signal Transduction,G protein signaling,G-Protein-Coupled Receptors(GPCR),Neuroscience,Cell Type Marker,Neurodegenerative Diseases,Dopamine Signaling in Parkinson's Disease,Neuron marker,Dendrite marker,DRD2
Molekulargewicht
47 kDa/50 kDa
Gen-ID
1813
UniProt
P14416
Pathways
Positive Regulation of Peptide Hormone Secretion , Negative Regulation of Hormone Secretion , cAMP Metabolic Process , Inositol Metabolic Process , Regulation of G-Protein Coupled Receptor Protein Signaling , Feeding Behaviour , Negative Regulation of Transporter Activity , Regulation of long-term Neuronal Synaptic Plasticity
Zuletzt angesehen
(ausblenden)